Zamboni WA, Wong HP, Stephenson LL, et al: Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb Med 24: 175, 1997.
Kranke P, Bennett M, Roeckl-Wiedmann I, et al: Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev (2): CD004124, 2004.
Hart GB, Strauss MB: Gas gangrene – clostridial myonecrosis: a review. J Hyperbaric Med 5: 125, 1990.
Escobar SJ, Slade JB, Hunt TK: Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med 32: 437, 2005.
Mader JT, Adams KR, Sutton TE: Infectious diseases: pathophysiology and mechanisms of hyperbaric oxygen. J Hyperbaric Med 2: 133, 1987.
Cianci P, Lueders H, Lee H, et al: Adjunctive hyperbaric oxygen reduces the need for surgery in 40-80% of burns. J Hyperbaric Med 3: 97, 1988.
Liu R, Li L, Yang M, et al: Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clinic Proc 88: 166, 2013.
Plafki C, Peters P, Almeling M, et al: Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med 71: 119, 2000
Leach RM, Rees PJ, Wilmshurst P: Hyperbaric oxygen therapy. BMJ 317: 1140, 1998.
Hyperbaric oxygen therapy (HBOT) is a useful tool for many conditions within the scope of practice of a Doctor of Podiatric Medicine (DPM). More wound-care clinics are adding HBOT as a service line. The increasing prevalence of DPMs operating inside of these wound-care clinics has raised questions about the licensure and privileging of DPMs to supervise HBOT. This document reviews the safety of outpatient HBOT and provides guidelines for hospitals to credential DPMs to supervise treatments.